The Noradrenergic System Is a Major Component in Parkinson’s Disease

doi 10.5772/17094
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

The Noradrenergic System in Parkinson’s Disease

Frontiers in Pharmacology
Pharmacology
2020English

Noradrenergic Dysfunction in Alzheimer's Disease

Frontiers in Neuroscience
Neuroscience
2015English

Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2016English

PARK11 and Gut-Microbiota in Parkinson’s Disease----- Is There a Link?

Journal of Critical Reviews
GeneticsMolecular BiologyPharmacologyBiochemistryToxicologyPharmaceutics
2020English

Titin Is a Major Human Disease Gene

Circulation
Cardiovascular MedicinePhysiologyCardiology
2013English

Midnolin Is a Confirmed Genetic Risk Factor for Parkinson’s Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2019English

Diagnosis of Parkinson’s Disease Using Principal Component Analysis and Boosting Committee Machines

Southeast Europe Journal of Soft Computing
2013English

Neuroinflammation Is a Key Player in Parkinson’s Disease and a Prime Target for Therapy

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

Sensory Attenuation in Parkinson’s Disease Is Related to Disease Severity and Dopamine Dose

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy